Biography

Graduated from Shanghai Jiaotong University School of Medicine with a doctorate, he is currently a cardiovascular researcher at the Affiliated Hospital of Panzhihua University. He used to be a cardiovascular associate researcher at Mount Sinai School of Medicine in the United States and published more than 30 medical papers, mainly engaged in the research of cardiomyopathy and heart failure.

Area of Interest:

Cellular and Molecular Biology

100%

Cardiology Research

62%

Cardiac Physiology

90%

Cardiovascular Pharmacology

75%

Cardiovascular Sciences

55%

Research Publications in Numbers

Books
0

Chapters
0

Articles
20

Abstracts
0

Selected Publications

Zhong, Z., Y. Tian, X. Luo, J. Zou, L. Wu and J. Tian, 2021. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells protect against DOX-induced heart failure through the miR-100-5p/NOX4 pathway. Front. Bioeng. Biotechnol., Vol. 9. 10.3389/fbioe.2021.703241.
CrossRef | Direct Link |
Yuan, Y., Y. Tao, Y. Deng, Q. Ye, B. Lin and L. Wu, 2019. BMP4 induces cardiomyocyte hypertrophy through the activation of ERK 1/2 signaling pathway in H9c2 cells. Braz. Arch. Biol. Technol., Vol. 62. 10.1590/1678-4324-2019180699.
CrossRef | Direct Link |
Yin, D., Q. Wan, Q. Ye, Y. Deng, B. Lin and L. Wu, 2019. Cardiomyocyte hypertrophy induced by visfatin in H9c2 embryonic rat cardiac cells via ERK1/2 signaling pathway. Int. J. Pharmacol., 15: 503-508.
CrossRef | Direct Link |
Luo, J., H. Liu, X. Zheng, B. Lin and Q. Ye et al., 2019. Inhibitory effect of apelin on cardiomyocyte hypertrophy induced by resistin in H9c2 cells. Int. J. Pharmacol., 15: 311-317.
CrossRef | Direct Link |
Zheng, X., H. Liu, G. Cheng, J. Luo, Q. Ye, Y. Deng and L. Wu, 2017. Odanacatib inhibits resistin-induced hypertrophic H9c2 cardiomyoblast cells through LKB1/AMPK pathway. Braz. Arch. Biol. Technol., Vol. 60. 10.1590/1678-4324-2017160333.
CrossRef | Direct Link |
Zheng, X., G. Cheng, J. Luo, Q. Ye, Y. Deng and L. Wu, 2017. Odanacatib inhibits resistin-induced cardiomyocyte hypertrophy through the inactivation of ERK signaling pathway. Int. J. Pharmacol., 13: 212-217.
CrossRef | Direct Link |
Luo, J.W., X. Zheng, G.C. Cheng, Q.H. Ye, Y.Z. Deng and L. Wu, 2016. Resistin-induced cardiomyocyte hypertrophy is inhibited by apelin through the inactivation of extracellular signal-regulated kinase signaling pathway in H9c2 embryonic rat cardiomyocytes. Biomed. Rep., 5: 473-478.
CrossRef | Direct Link |
Liu, P., G.C. Cheng, Q.H. Ye, Y.Z. Deng and L. Wu, 2016. Lkb1/ampk pathway mediates resistin-induced cardiomyocyte hypertrophy in h9c2 embryonic rat cardiomyocytes. Biomed. Rep., 4: 387-391.
CrossRef | Direct Link |
Liu, P., G.C. Cheng, Q.H. Ye, Y.Z. Deng and L. Wu, 2016. LKB1/AMPK pathway mediates resistin-induced cardiomyocyte hypertrophy in H9c2 embryonic rat cardiomyocytes. Biomed. Rep., 4: 387-391.
CrossRef | Direct Link |
Wang, L., L. Wu, X. Wang, J. Deng and Z. Ma et al., 2015. Prenatal alcohol exposure inducing the apoptosis of mossy cells in hippocampus of SMS2−/− mice. Environ. Toxicol. Pharm., 40: 975-982.
CrossRef | Direct Link |
Kielczewski, J.L., S.L. Calzi, L.C. Shaw, J. Cai and X. Qi et al., 2011. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase). Invest. Ophthalmol. Vis. Sci., 52: 8278-8286.
CrossRef | Direct Link |
Cai, J., L. Wu, X. Qi, S.L. Calzi and S. Caballero et al., 2011. PEDF regulates vascular permeability by a γ-secretase-mediated pathway. PLoS ONE, Vol. 6. 10.1371/journal.pone.0021164.
CrossRef | Direct Link |
Cai, J., L. Wu, X. Qi, L. Shaw and S.L. Calzi et al., 2011. Placenta growth factor-1 exerts time-dependent stabilization of adherens junctions following VEGF-induced vascular permeability. PLoS ONE, Vol. 6. 10.1371/journal.pone.0018076.
CrossRef | Direct Link |